CA

Marie-Eve Hamelin

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, National Institute of Health and Medical Research. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie-Eve Hamelin. Retrieved from https://idiyas.com/inventor/marie-eve-hamelin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marie-Eve Hamelin: Innovator in Vaccine Development

Introduction

Marie-Eve Hamelin is a notable inventor based in Canada, recognized for her contributions to the field of vaccine development. She has made significant strides in the research of attenuated virus strains, particularly in relation to human metapneumovirus.

Latest Patents

Marie-Eve Hamelin holds a patent for an attenuated virus strain and its use as a vaccine. The invention pertains to a virus strain derived from a human metapneumovirus, which includes genetic modifications that reduce the virulence of the strain. This innovation has the potential to enhance vaccine efficacy and safety.

Career Highlights

Throughout her career, Marie-Eve has worked with esteemed institutions such as Université Claude Bernard Lyon 1 and the Centre National de la Recherche Scientifique. Her work has been pivotal in advancing the understanding of viral pathogens and their applications in vaccine technology.

Collaborations

Marie-Eve has collaborated with notable researchers, including Manuel Rosa-Calatrava and Guy Boivin. These partnerships have contributed to her success in the field and have fostered advancements in vaccine research.

Conclusion

Marie-Eve Hamelin's innovative work in vaccine development exemplifies her commitment to improving public health through scientific research. Her contributions continue to influence the field of virology and vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…